Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Alterity Therapeutics Limited - Sponsored ADR (ATHE) Weighted-Average Shares Outstanding (Diluted) data is not available.
Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
Weighted-Average Shares Outstanding (Diluted) |
-- |
-- |
|
-- |
|
Balance Sheet Financials | |
$29.71M |
|
-- |
|
-- |
|
$29.81M |
|
$2.29M |
|
-- |
|
-- |
|
$2.35M |
|
$27.46M |
|
$27.46M |
|
$27.46M |
|
-- |
|
Cash Flow Statement Financials | |
$-7.42M |
|
$-4.86M |
|
$25.69M |
|
$8.19M |
|
$21.47M |
|
$13.29M |
|
-- |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |